Apolipoprotein E and cognitive change in an elderly population

Annals of Neurology

Volumn 40, Issue 1, 1996, Pages 55-66

  Hyman, B T ^a   Gomez Isla, T ^a   Briggs, M ^a   Chung, H ^a   Nichols, S ^b   Kohout, F ^b   Wallace, R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MENTAL TEST; PRIORITY JOURNAL; PROGNOSIS; RECALL; RISK FACTOR;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CHOLESTEROL, HDL; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 0029996705     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400111     Document Type: Article

References (49)

1. Ordovas JM, Litwack-Klein L, Wilson PWF, et al. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987;28:371-380
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630
3. Hallman D, Boerwinkle E, Saha N, et al. The apoliprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Gent 1991;49:338-349
4. Strittmatter Wf, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
5. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711
6. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease; allelic variation and receptor interactions. Neuron 1993;11:575-580
7. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923
8. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
9. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699
10. Tsai M-S, Tangalos EG, Petersen RC, et al. Apoliprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54: 643-649
11. Chartier-Harlin M-C, Parfitt M, Legrain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574
12. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuroparhol Exp Neurol 1994;53:429-437
13. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
14. Rebeck GW, Perls TT, West HL, et al. Reduced apolipoprotein E4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516
15. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737 (Letter)
16. Payami H, Kaye J, Heston LL, et al. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:738 (Letter)
17. Liddell M, Williams J, Bayer A, et al. Confirmation of association between the ε4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet 1994;31:197-200
18. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-638
19. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994;145:1472-1484
20. van Duijn C, de Kniff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-78
21. Corder EH, Saunders AM, Risch NJ, et al. Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease. Nature Genet 1994;7:180-184
22. Smith AD, Johnston C, Sim E, et al. Protective effect of apoE ε2 in Alzheimer's disease. Lancet 1994;344:473-474
23. Benjamin R, Leake A, McArthur FK, et al. Protective effect of apoE ε2 in Alzheimer's disease. Lancet 1994;344:473
24. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48
25. Roses A. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995; 38:6-14
26. Riggs J, Keefover R. The association between apolipoprotein E allele ε4 and late onset Alzheimer's disease: pathogenic relationship or differential survival bias? Arch Neurol 1994;51:750
27. Bird T. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995;38:2-4
28. Colsher PL, Wallace RB. Longitudinal application of cognitive function measures in a defined population of community-dwelling elders. Ann Epidemiol 1991;1:215-230
29. White L, Katzman R, Losonczy K, et al. Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol 1994;47:363-374
30. Coroni-Huntley J, Brock D, Ostfeld A, et al. National Institute on Aging Established Populations for Epidemiologic Studies of the Elderly: resource book. Bethesda, MD: National Institutes of Health, 1986
31. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Psychiatric Soc 1975;23:433-441
32. O'Hara M, Hinrichs J, Kohout F, et al. Memory complaint and performance in depressed elderly. Psychol Aging 1986;3: 208-214
33. Katz S, Ford A, Moskowitz R, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:221-229
34. Rosow I, Breslau N, Gutman A. Health scale for the aged. J Gerontol 1966;21:556
35. Colsher P, Wallace R. Data quality and age: health and psychobehavioural correlates of item nonresponse and inconsistent responses. J Gerontol 1989;44:45-52
36. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548
37. Hyman BT, West HL, Rebeck GW, et al. Neuropathological changes in Down's syndrome hippocampal formation: effect of age and apolipoprotein E genotype. Arch Neurol 1995;52: 373-378
38. Linn R, Wolf P, Bachman D, et al. The "preclinical phase" of probable Alzheimer's disease. Arch Neurol 1995;52:485-490
39. Jacobs D, Sano M, Dooneief G, et al. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995;45:957-962
40. Locasio J, Growdon J, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol 1995;52:1087-1099
41. Jarvik G, Wijsman E, Kukull W, et al. Interactions of apolipoprotein E genotype, total cholesterol, age, and sex in prediction of Alzheimer's disease: a case control study. Neurology 1995; 45:1092-1096
42. Feskens E, Havekes L, Kalmijn S, et al. Apolipoprotein E and cognitive decline in elderly men. BMJ 1994;309:1202-1206
43. Henderson A, Easteal S, Jorm A, et al. Apolipoprotein E allele 4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390
44. Gomez-Isla T, West H, Rebeck G, et al. Distinct clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 1996;39:62-70
45. Payami H, Montee K, Kaye J, et al. Alzheimer's disease, apolipoprotein E and gender. JAMA 1994;271:1316-1317 (Letter)
46. Corder E, Saunders A, Strittmatter W, et al. The apolipoprotein E ε4 allele and sex-specific risk of Alzheimer's disease. JAMA 1995;273:373-374 (Letter)
47. Myers R, Schaefer E, Wilson P, et al. Apolipoprotein E allele 4 is associated with dementia in the Framingham Study. In: Iqbal K, Mortimer J, Winblad B, Wisniewski H, eds. Research advances in Alzheimer's disease and related disorders. Chichester, England: Wiley, 1995:63-72
48. Davignon J, Bouthillier D, Nestruck A, et al. Apolipoprotein E polymorphism and atherosclerosis: insight from a study of octagenarians. Trans Am Clin Climatol Assoc 1987;99:100-110
49. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E ε4 with late onset Alzheimer's disease among Finnish centanarians. Neurology 1995;45:903-907